CHAMPIONS ONCOLOGY, INC. Logo

CHAMPIONS ONCOLOGY, INC.

Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.

CSBR | NDAQ

Overview

Corporate Details

ISIN(s):
US15870P3073
LEI:
549300O8WKLP8QEG5U47
Country:
United States of America
Address:
855 N. WOLFE STREET, 21205 BALTIMORE
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Champions Oncology, Inc. is a global contract research organization (CRO) specializing in end-to-end oncology drug development solutions. The company partners with pharmaceutical and biotech firms to accelerate research from discovery to clinical success. Its core offerings are built upon a proprietary, clinically relevant bank of over 1,400 patient-derived xenograft (PDX) models. This is integrated with a comprehensive multi-omic data platform, containing over two billion data points, accessible through its Lumin software for advanced analytics and visualization. Champions provides a suite of preclinical and clinical specialty testing services, including high-complexity flow cytometry, next-generation sequencing, histology, and radiopharmaceutical development, enabling data-driven decisions and biomarker discovery.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all CHAMPIONS ONCOLOGY, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CHAMPIONS ONCOLOGY, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CHAMPIONS ONCOLOGY, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Developing nanomedicines and drug delivery systems for oncology, hematology, and diagnostics.
Malaysia N/A
A holding company driving regional growth by supporting construction, HR, and nursing care businesses.
Japan 7369
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America M3D
MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan 9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan 9227
MindWalk Holdings Corp. Logo
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America HYFT
Minerva Neurosciences, Inc. Logo
A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.
United States of America NERV
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan 3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan 4883

Talk to a Data Expert

Have a question? We'll get back to you promptly.